AddTweet This Post to Facebook hEmail this
‹‹ Go Back

Gary Warren, BS, MS

President and CEO, ivWatch, LLC, Williamsburg, Virginia

Gary P. Warren is the President and CEO of ivWatch, LLC.

‹‹ Go Back

Gregory Schears, MD

Associate Professor of Anesthesiology, Medical Director of ECMO Services, Physician Liaison for the Nurse-led PICC team, Mayo Clinic, Rochester, Minnesota

presenter photoDr. Schears is a pediatric Intensivist and anesthesiologist with a long standing interest in reducing patient complications and improving our approach to vascular access. He did his pediatric residency at St. Louis Children's Hospital, his anesthesia residency, pediatric anesthesia fellowship and pediatric critical care fellowship at John's Hopkins hospital. He worked at the Children's Hospital of Philadelphia for 5 years and was recruited to the Mayo Clinic in 2001 to head the ECMO service. There he is the physician liaison to the nurse led PICC team, Medical Director of the ECMO Service and Co-Director of the Congenital Heart Unit. He is on the editorial board for JAVA and serves on the AVA Board of Directors as Treasurer. He is very active with product development to help reduce complications and has given hundreds of presentations locally, regionally, nationally and internationally.

‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

Symposia

Finally, Development of an Aid for Early Detection of Infiltrations

calendar9/9/2014

clock7:00 AM - 8:45 AM

clockRoom: National Harbor 10-11

Gary Warren, BS, MS

President and CEO, ivWatch, LLC, Williamsburg, Virginia

Gregory Schears, MD

Associate Professor of Anesthesiology, Medical Director of ECMO Services, Physician Liaison for the Nurse-led PICC team, Mayo Clinic, Rochester, Minnesota

Early detection of peripheral IV (PIV) infiltrations and extravasations is a large unmet need for infusion therapy. During this session, we will explore how the cards are stacked against the clinician when using scheduled IV site inspections to diagnose a PIV infiltration. The development of continuous PIV site monitoring products will be presented along with the clinical design and data used for products in the ivWatch pipeline.

Learning Objectives:

  • Upon completion, participant will be able to understand various theories around the causes of infiltration and understand the difference between prevention and early detection.
  • Participant will also understand the limitations of periodic inspection of peripheral IV sites and how these limitations change with flow rate and inspection frequency.
  • Participant will gain a working knowledge of various products on the market that can help with early infiltration detection including products under development that provide continuous monitoring of the PIV site.


Supported by:

832 Views